Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Another late-stage round brings $51.2mm to TransMedics; $12.5mm added

Executive Summary

TransMedics Inc. raised $51.2mm through a late-stage funding round (likely its Series I) from co-lead investors Fayerweather Fund, Pharmstandard International (represented by InBio Ventures), Ervington Investments, and BioStar Ventures. Existing investors Abrams Capital, Lung Biotechnology PBC, Flagship Ventures, and Kleiner Perkins Caufield & Byers also participated. TransMedics markets the Organ Care System, the first ever portable warm blood perfusion system for living organ transplants.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register